-
Ocugen and Kwangdong Pharma complete license agreement of OCU400 modifier gene therapy for retinitis pigmentosa in Korea
16 Sep 2025 05:32 GMT
… novel modifier gene therapy for retinitis pigmentosa (RP).
Pursuant to the License …
-
Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea
15 Sep 2025 10:03 GMT
… novel modifier gene therapy for retinitis pigmentosa (RP). Pursuant to the License …
-
‘Kaun Banega Crorepati 17’: Blind IAS Officer Ayushi Easily Answers THIS INR 5 Lakh Question on British India Rule, Can You?
16 Sep 2025 18:04 GMT
… suffers from a condition called retinitis pigmentosa. Her mother explained that Ayushi …
-
Q&A: Sofia Androudi on retinal disorders mimicking inherited retinal diseases
16 Sep 2025 13:21 GMT
… heterogeneous disease. For instance, a retinitis pigmentosa can look like Leber congenital …
-
Ocugen and Kwangdong Finalize Licensing Agreement for OCU400 Gene Therapy in South Korea
16 Sep 2025 12:58 GMT
… modifier gene therapy candidate for retinitis pigmentosa (RP), in South Korea.
Agreement … : A Modifier Gene Therapy for Retinitis Pigmentosa
OCU400 is a potential one … gene therapy designed to treat retinitis pigmentosa (RP) by targeting the genetic …
-
Clinical Research for Inherited Retinal Disease Related Pediatric Blindness: A Preliminary Descriptive Analysis Based on ClinicalTrials.gov
16 Sep 2025 09:23 GMT
… retinal diseases like X-linked retinitis pigmentosa, achromatopsia, Leber hereditary optic … retinal diseases like X-linked retinitis pigmentosa, achromatopsia, Leber hereditary optic … Kalevar A, Tran SD. Retinitis pigmentosa: novel therapeutic targets and drug …
-
No handicap: America’s ultracompetitive — and uplifting — blind golfers’ trophy drive is in full swing
16 Sep 2025 03:49 GMT
… at 40, the result of retinitis pigmentosa, a degenerative condition that affects …
-
Why Ocugen Stock Zoomed 12% Higher Today
16 Sep 2025 03:15 GMT
… OCU400, an investigational drug targeting retinitis pigmentosa (RP). This is a disorder …
-
Ocugen and Kwangdong complete licensing agreement for OCU400 gene therapy in Korea
16 Sep 2025 00:28 GMT
… novel modifier gene therapy for retinitis pigmentosa (RP).1
It was announced …
-
Ocugen Shares Are Trading Higher Monday: What's Going On?
15 Sep 2025 21:06 GMT
… , its modifier gene therapy for retinitis pigmentosa. The deal marks Ocugen… individuals in Korea living with retinitis pigmentosa, representing roughly 7% of the …
About
© 1995-2025